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A B S T R A C T
Accidental exposure to ionizing radiation is a serious concern to human life. Studies on the mitigation of side
effects following exposure to accidental radiation events are ongoing. Recent studies have shown that radiation
can activate several signaling pathways, leading to changes in the metabolism of free radicals including reactive
oxygen species (ROS) and nitric oxide (NO). Cellular and molecular mechanisms show that radiation can cause
disruption of normal reduction/oxidation (redox) system. Mitochondria malfunction following exposure to ra-
diation and mutations in mitochondria DNA (mtDNA) have a key role in chronic oxidative stress. Furthermore,
exposure to radiation leads to infiltration of inflammatory cells such as macrophages, lymphocytes and mast
cells, which are important sources of ROS and NO. These cells generate free radicals via upregulation of some
pro-oxidant enzymes such as NADPH oxidases, inducible nitric oxide synthase (iNOS) and cyclooxygenase-2
(COX-2). Epigenetic changes also have a key role in a similar way. Other mediators such as mammalian target of
rapamycin (mTOR) and peroxisome proliferator-activated receptor (PPAR), which are involved in the normal
metabolism of cells have also been shown to regulate cell death following exposure to radiation. These me-
chanisms are tissue specific. Inhibition or activation of each of these targets can be suggested for mitigation of
radiation injury in a specific tissue. In the current paper, we review the cellular and molecular changes in the
metabolism of cells and ROS/NO following exposure to radiation. Furthermore, the possible strategies for mi-
tigation of radiation injury through modulation of cellular metabolism in irradiated organs will be discussed.
1. Introduction
Nowadays, exposure to ionizing radiation is almost inevitable.
Ionizing radiation is applied in some industries such as nuclear industry
as well as in the agricultural sector [1]. Radioactive sources are mostly
utilized in nuclear power plants. However, ionizing radiation is widely
used in medicine for diagnostic or therapeutic aims. Nuclear medicine,
radiotherapy and brachytherapy rely heavily on radioactive sources
[2]. In spite of the useful aims of ionizing radiation and radioactive
sources, there are some concerns for possible threats which are asso-
ciated with its usage. One of the most devastating disasters from the
peaceful usage of ionizing radiations in the nuclear industry is the
Chernobyl nuclear power plant accident. This accident caused the re-
lease of huge amounts of radioactive elements including iodine and
cesium, which led to the death of some exposed people. Furthermore, it
had negative effects on the environment, leading to increased incidence
of cancer in some exposed people many years after [3].
In addition to the mentioned threats from peaceful applications of
radioactive sources, there are serious concerns about the use of radio-
active and nuclear sources for war or terror [4]. An example of such
incidents was the nuclear bomb explosions in Hiroshima and Nagasaki
during World War 2, which also had its own consequences years after.
Furthermore, dirty radioactive sources may also be used for terror aims
[5]. People who are exposed to ionizing radiation may die or show
some serious side effects which affect their quality of life for many years
[6]. As a fallout of these threats, it is imperative to implement strategies
aimed at preventing these disasters arising from exposure to ionizing
radiation. To achieve this aim, it is important to have the knowledge
about the mechanisms through which ionizing radiation cause damages
to cells, especially in some critical organs such as the bone marrow,
lung, heart as well as the gastrointestinal and neurovascular systems
[7].
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It is well-known that ionizing radiation attack DNA directly or via
radiolysis of water molecules. Classical hypothesis in radiobiology
suggests that the final consequences of ionizing radiation are as a result
of DNA damage at the first moments after exposure. This dogma was
challenged following some evidences which showed that damages to
non-irradiated cells was due to the release of some unknown clastogenic
factors from irradiated cells. Furthermore, it was observed that ex-
posure to ionizing radiation can lead to continuous production of free
radicals [8]. The use of antioxidants some days after exposure to ra-
diation has confirmed that a remarkable amount of toxic consequences
of ionizing radiation is as a result of some changes within the cells,
thereby leading to an increase in the production of free radicals and
amplification of radiation toxicity [9].
Results of experimental studies suggest that abnormal changes in
the metabolism of reactive oxygen species (ROS) and nitric oxide (NO)
have a key role in potentiating genotoxic effects of ionizing radiation
[10]. Evidence suggests that exposure to radiation causes an increase in
the ROS/NO sources within tissues [11]. In this paper, we aimed to
review the cellular and molecular mechanisms of reduction/oxidation
(redox) reactions following exposure to radiation and their potential
targets for mitigation of radiation injury.
2. Radiation-induced DNA damage triggers systemic redox
reactions
Interactions involving ionizing radiation and free radicals with DNA
introduce biological consequences in irradiated and also non-irradiated
cells/tissues. Although it is well known that damage to other organelles
such as membrane and mitochondria by radiation is involved in ra-
diation toxicity, it seems that chronic oxidative stress and inflammatory
reactions are as a result of massive DNA damage and cell death fol-
lowing exposure to radiation. This issue has been observed in studies
showing that heavy charged particles cause severe release of damage-
associated molecular pattern (DAMP) and chronic oxidative stress (a
phenomenon that may occur in low severity following low linear energy
transfer (LET) radiation) [12,13]. Indeed, inflammatory cells detect
DNA damage and cell death through apoptotic bodies after apoptosis or
release of DAMPs including high-mobility-group Box 1 (HMGB1), uric
acid, oxidized DNA, ATP, heat shock proteins (HSPs) and some other
molecules that will be released following necrosis, necroptosis and
autophagy [14]. Apoptotic bodies will be absorbed by macrophages,
leading to tolerogenic responses as well as the release of TGF-β and IL-
10. However, the release of danger alarms triggers inflammatory re-
sponses through upregulation of toll like receptors (TLRs), NF-κB, in-
ducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), in-
tracellular adhesion molecule-1 (ICAM-1), vascular cell adhesion
molecule-1 (VCAM-1) and finally inflammatory cytokines such as IL-1,
IL-6, IL-8, IL-33, TNF-α and IFN-γ. These changes are associated with
infiltration of inflammatory cells and also the release of intercellular
mediators such as vesicles, exosomes and microRNAs [15,16].
Released cytokines and other intercellular mediators are able to
migrate to other adjacent cells or distant organs, leading to activation of
inflammatory reactions and redox interactions. This causes amplifica-
tion of radiation toxicity in irradiated tissues and also induction of
oxidative injury and DNA damage in non-irradiated cells [17]. Thus,
identification of intercellular communication and mediators that are
involved in the bystander effect may help the exploration of new targets
for mitigation of radiation injury. Experimental studies have confirmed
this hypothesis. For example, the suppression of TGF-β, TNF-α and
COX-2 in bystander cells or non-targeted tissues has been shown to
ameliorate radiation-induced oxidative injury [18–20]. Targeting of
these proteins has also been shown to ameliorate early and late con-
sequences of exposure to radiation in irradiated organs [21–23]. It
seems that inflammation and oxidative stress have close relation with
each other in irradiated or bystander tissues. Thus, inhibition of some
inflammatory targets such as COX-2 and iNOS can lead to reduction of
ROS and NO, which lead to mitigation of radiation injury [24–28].
3. Redox metabolism after radiation
Emerging evidences have shown that cellular metabolism plays a
key role in endogenous production of free radicals a long time after
exposure to ionizing radiation [29,30]. ROS generating sources within
cells play a key role in the regulation of metabolism and cell pro-
liferation. The mitochondria are known as the energy supplier of cells
via generation of ATP. It supplies ROS which trigger cell proliferation in
most cell types [31]. NADPH oxidase enzymes also produce ROS that is
critical for degradation of pathogens. However, ROS derived NADPH
oxidase has a role in proliferation of stem/progenitor cells [32]. The
role of NADPH oxidase in bone marrow stem cell function is critical.
The production of hydrogen peroxide (H2O2) by NADPH oxidase en-
zymes can trigger differentiation of stem/progenitor cells in the bone
marrow, while lower levels of H2O2 cause stemness of stem/progenitor
cells [33]. Ionizing radiation can cause an abnormal increase in mi-
tochondria and NADPH oxidase activity, leading to the generation of an
unusual amount of ROS. This causes overwhelming antioxidant cell
defense and damage to stem/progenitor cells. For example, upregula-
tion of NOX4 or higher activity of mitochondria in the bone marrow
following exposure to radiation is associated with an increase in ROS,
apoptosis and senescence in stem cells [34,35]. Metformin, which is
known as an inhibitor of mitochondria, is able to mitigate radiation
toxicity in bone marrow stem cells [36]. Metabolisms of glucose and
lipids are also increased following exposure to radiation, and it seems to
be involved in the progression of radiation-induced normal tissue
toxicity [37]. Mammalian target of rapamycin (mTOR) and peroxisome
proliferator-activated receptor (PPAR) are two important metabolic
mediators whose roles have been confirmed in radiation toxicity. Ac-
tivation of these mediators also plays a key role in tumor growth and
angiogenesis [38,39]. Thus, inhibition of these targets may be sug-
gested for protection of normal tissues without negative effects on
tumor response to radiotherapy. Thus, targeting oxygen, glucose and
lipid metabolism can be suggested for protection and mitigation of
radiation injury.
4. mTOR
mTOR is a critical protein kinase that is involved in the regulation of
cell growth, cell death, cancer and metabolism [40]. Targeting mTOR
by rapamycin is a known strategy for tumor suppression [41,42].
However, some studies have suggested that it may play a role in normal
tissue injury. MTOR can be upregulated by PI3K/Akt and MEK1/
2–ERK1/2 pathways as well as some growth factors and hormones [41].
mTOR targeting may cause reduction of stem cells' apoptosis and trig-
gers their proliferation, leading to mitigation of radiation toxicity.
Treatment of irradiated mice with rapamycin has been shown to sti-
mulate cell proliferation and reduce apoptosis. This caused an increase
in CD133+ renal stem cells. Rapamycin has also been shown to at-
tenuate the upregulation of NF-κB and TGF-β in the kidney, two im-
portant mediators of fibrosis and inflammation [43,44]. Similar results
have been obtained for parotid acinar cells following head and neck
irradiation in mice. The parotid gland has highly radiosensitive stem
cells. Damages to these cells may be involved in mucositis and xer-
ostomia for patients that undergo radiotherapy for head and neck
cancers. Inhibition of mTOR by CCI-779 in mice has shown promising
results for preserving cells in parotid glands [45]. It seems that in-
hibition of mTOR can protect normal tissues via suppression of radia-
tion-induced senescence. A study has shown that rapamycin reduces
senescence after irradiation in primary human keratinocytes and epi-
thelial stem cells. Further analyses showed that rapamycin triggers
activation of MnSOD, which neutralizes free radicals and prevents se-
nescence. This is associated with reduction of stem cell death and
mucositis in mice tongue [46]. Senescence plays a key role in the
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development of fibrosis following pulmonary exposure to radiation
[47]. Therefore, it is predictable that suppression of mTOR may be an
appropriate candidate for amelioration of fibrosis. This hypothesis has
been confirmed in an experimental study by Dai et al. [48]. Chung et al.
investigated the effect of mTOR inhibition for mitigation of radiation-
induced pulmonary fibrosis. They showed that treatment with rapa-
mycin is associated with reduction of senescence and pro-fibrotic cy-
tokines including IL-1β and TGF-β [49] (Fig. 1).
5. PPARs
PPARs are ligands that regulate several metabolic pathways such as
metabolism of fatty acids [50]. They include some subfamilies such as
PPARα, PPARβ, PPARб and PPARγ [51]. The proteins have an im-
portant role in the metabolism of fatty acids and glucose, and also in the
immune system [52]. Due to their role in the regulation of immune
system, it has been suggested that PPARs may have a critical role in
inflammatory responses as observed after radiotherapy. One of the
important functions of PPARs is suppression of NF-κB, a critical reg-
ulator of many inflammatory responses. This effect is mediated through
upregulation of IκBα, which can degrade NF-κB [53]. PPARα knock out
has been shown to increase the expression of NF-κB. However, this
reduces apoptosis and radiosensitivity in the kidney [54]. PPARs also
have a negative relationship with the expression of TGF-β in irradiated
cells [55,56]. These properties of PPARs may aid protection and miti-
gation against toxic consequences of ionizing radiation on normal tis-
sues. In vitro studies have confirmed that activation of PPARα and
PPARб can reduce inflammation and oxidative stress in microglia cells
[57,58]. An in vivo study also confirmed that PPARα agonist can reduce
injury to microglia and preserve hippocampal neurogenesis following
whole brain irradiation [59].
Mangoni et al. have shown that PPAR agonists can protect the in-
testine via suppression of NF-κB. They used rosiglitazone, an agonist of
PPARγ before whole-body irradiation of mice. Treatment with PPARγ
agonist reduced damages to crypts and villi as well as ameliorated in-
flammation in the intestine. Rosiglitazone also reduced the induction of
apoptosis. Molecular assays showed that rosiglitazone suppresses the
expression of NF-κB and TGF-β, two important inducers of inflamma-
tion and apoptosis. This was associated with reduction in inflammatory
cytokines' levels [60]. Similar results have been obtained for the lung.
Suppression of both NF-κB and TGF-β using rosiglitazone ameliorated
pneumonitis and fibrosis [61]. These consequences of PPAR activation
by rosiglitazone have also been suggested to reduce the severity of ra-
diation-induced mucositis [62].
6. NADPH oxidases
NADPH oxidases are a group of enzymes that generate H2O2 via
transferring an electron to oxygen. These enzymes include five sub-
families that are known as NADPH oxidase (NOX)1–5. Furthermore,
two other enzymes including dual oxidase (Duox)1 and 2 are involved
in ROS production. Under normal conditions, ROS production by these
enzymes helps immune cells kill pathogens and pre-cancerous cells. The
activity of these enzymes is regulated by some cytokines and growth
factors such as IL-1, IL-4, IL-13 and TGF-β. These cytokines are potent
inducers of fibrosis. Thus, there is a possibility that NADPH oxidase
enzymes play a key role in the development of fibrosis following ex-
posure to ionizing radiation. It has been confirmed that upregulation of
NOX1 in the lung can potentiate differentiation of fibroblasts.
Furthermore, NOX2 and NOX4 can produce ROS for long periods of
time after lung irradiation, thereby mediating oxidative stress [63]. The
production of superoxide by NOX1 has also been shown to potentiate
apoptosis induction in salivary gland acinar cells. Selective inhibition of
NOX1 in the salivary gland acinar cells (NS-SV-AC) showed reduction of
apoptosis, which is mediated by ROS derived NOX1 enzyme [64].
Upregulation of NOX2 and NOX4 may be involved in radiation-in-
duced bystander and non-targeted effect, a phenomenon that causes
ROS generation in neighboring non-irradiated cells or distant organs
[17]. It has been shown that NOX4 and NOX5 have a role in oxidative
stress in human fibroblast cells. Inactivation of these enzymes using
fulvene-5, a NOX-specific inhibitor showed reduction of ROS level and
DNA damage after irradiation [65]. One of the most interesting
Fig. 1. Mechanisms of mTOR activation after exposure to radiation and its role in the development of fibrosis.
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properties of NOX system is continuous generation of ROS in highly
radiosensitive organs including the bone marrow and intestine. It seems
that NOX2 and NOX4 are the most important redox enzymes which
amplify radiation toxicity in these organs. In mice bone marrow cells,
upregulation of NOX4 has been investigated for 8 weeks after whole-
body irradiation. Inactivation of NOX4 has been shown to augment
survival and reduce genomic instability. The upregulation of NOX en-
zymes has also been investigated in mice intestine and was suggested as
a source of ROS which mediates chronic oxidative stress for a long time
after irradiation. It seems that upregulation of NOX enzymes also plays
a key role in chronic inflammation via triggering infiltration of in-
flammatory cells.
Duox1 and Duox2 are other subfamilies that produce H2O2. The
most common action of these enzymes is regulating thyrocyte cell
function to release thyroxin (T4) and triiodothyronine (T3) [66]. It has
been confirmed that high activities of these enzymes are associated
with genomic instability and carcinogenesis [67]. In response to io-
nizing radiation, Duox1 is upregulated and generates higher amount of
H2O2 for long periods of time. It has been confirmed that an increase in
IL-13 is responsible for continuous production of ROS by Duox1 [68]. It
seems that upregulation of both Duox1 and Duox2 is involved in the
late effect of ionizing radiation which occurs following an increase in
IL-4 or IL-13. Infiltration of inflammatory cells and fibrosis have been
associated with upregulation of these enzymes [67].
7. Mitochondria
It seems that the mitochondria are the main source of ROS gen-
eration for most cells. During oxidative phosphorylation (OXPHOS) the
redox reactions in electron transient chain (ETC) lead to superoxide
production [69]. Under normal conditions, superoxide is neutralized by
superoxide dismutase (SOD) and catalase to prevent toxic effects on
vital organelles. Any disruption in the normal OXPHOS can cause
overproduction of superoxide by mitochondria, leading to over-
whelming antioxidant defense by SOD and catalase. This causes oxi-
dative damage to DNA, organelles, proteins and also lipids within cells
and in membrane [70]. Ionizing radiation is able to cause several mu-
tations in mitochondrial DNA (mtDNA) [71]. Studies have shown that
mutations in mtDNA after exposure to radiation lead to chronic over-
production of superoxide, which itself triggers production of ROS from
other pro-oxidant enzymes in a positive feedback loop [72]. Damages to
the DNA nucleus can also trigger mitochondria ATP generation. It
seems that cell-cycle kinase CDK1 plays a key role in this pathway.
After DNA damage, an increase in CDK1 can stimulate ATP generation
and OXPHOS in the mitochondria. This is associated with DNA damage
and inhibition of DNA repair [73]. Also, cell death after exposure to
ionizing radiation has a key role in stimulating oxygen metabolism and
generation of ROS by the mitochondria and other pro-oxidant enzymes.
Apoptosis and senescence trigger the release of TGF-β by macrophages,
while necrosis may lead to the release of inflammatory cytokines that
amplify radiation toxicity via triggering ROS generation [29,74,75]. As
earlier mentioned, senescence can stimulate some side effects such as
fibrosis following exposure to ionizing radiation. Mitochondrial dys-
function can trigger senescence after exposure to ionizing radiation. It
has been shown that radiation-induced mitochondrial respiratory
complex II dysfunction causes overproduction of superoxide, which is
associated with oxidative stress and cell death through senescence [76].
In mice intestine, ROS production by the mitochondria has been in-
vestigated for one year after irradiation [12]. Furthermore, in vitro
studies have shown that the mitochondria are responsible for ROS
overproduction and genomic instability in the progeny of irradiated
cells [77,78]. Damage to mtDNA can also release vesicles that cause
oxidative injury in bystander cells [79]. This shows that the mi-
tochondria play a key role in chronic oxidative injury after exposure to
ionizing radiation, thus its targeting could help protect and mitigate
radiation-induced oxidative injury.
To date, many studies have shown that suppression of mitochondria
via selective inhibitors or some other agents mitigates oxidative stress.
On the other hand, some agents that neutralize free radicals to prevent
mitochondrial injury can mitigate radiation injury, probably via redu-
cing mitochondrial malfunction [80]. Targeting the mitochondria via
mitochondrial inhibitors or mitochondrial antioxidants has been shown
to reduce ROS generation, DNA damage and cell death [81–84]. One of
the interesting mitochondrial inhibitors is metformin [85]. Pre-irra-
diation treatment with metformin has been shown to reduce genotoxic
effects of radiation such as DNA damage, micronuclei formation and
apoptosis [86]. Pre and post-irradiation treatments with metformin has
shown radioprotective effects for some organs such as intestine, colon,
kidney, lung and heart [87–91]. Administration of metformin only after
irradiation can mitigate radiation-induced hematopoietic injury,
pneumonitis and fibrosis, which are associated with reduction of TGF-β
[92–94]. In a clinical study, administration of metformin was shown to
improve the number of peripheral white cells in patients treated with
radioactive iodine for thyroid cancer [95].
One of the interesting strategies for targeting the mitochondria is
the use of mitochondria antioxidants or some agents that neutralize
superoxide generated by the mitochondria selectively [96]. The de-
livery of SOD2 (MnSOD) into the mitochondria has been shown to re-
duce radiation damage in irradiated cells [97–100]. JP4-039 is a mi-
tochondria-targeted nitroxide that is concentrated in the mitochondria,
neutralizes and acts as an SOD mimic. Administration of JP4-039 after
whole body irradiation with a lethal dose of radiation can mitigate
radiation injury and increase survival [101]. It has been shown to re-
duce oxidative stress and cell death in the bone marrow, thus mitigates
lethal effects of ionizing radiation [102–105]. Rajagopalan et al. eval-
uated the effect of JP4-039 for mitigation of radiation injury following
exposure to a lethal dose of radiation. They showed that JP4-039 helps
DNA repair after irradiation [106]. JP4-039 can reduce epithelial cells'
necrosis in the small intestine and help stem cells' recovery. These are
associated with suppression of inflammation in the intestine [107]. The
protective effect of JP4-039 on epithelial cells has also been confirmed
for oral and esophageal mucus, while it showed no protective effect for
cancer cells [108–110]. To date, some different analogues of JP4-039
have been explored to increase protective and mitigatory effects against
radiation [111,112]. Furthermore, some other types of mitochondrial
antioxidants such as MnTE-2-PyP5+, tempol and glutathione perox-
idase 4 mimic Mito-Ebselen have been developed [113–119].
8. Nitric oxide synthases (NOSs)
NO is a product of macrophages via upregulation of iNOS. NO has a
higher half-life compared to ROS and is able to attack DNA. Also, it can
combine with superoxide generated by mitochondria to generate per-
oxynitrite. Peroxynitrite can attack the DNA and cause nucleotide da-
mage directly. Interaction of peroxynitrite with the DNA leads to for-
mation of 8-nitroguanine or oxidation of deoxyribose, which give rise to
an abasic site and single strand break (SSB). Peroxynitrite can also
cause oxidation and degradation of guanine [120]. Another mechanism
of peroxynitrite is induction of DNA damage and cell death through
modulation of DNA repair mechanisms. Peroxynitrite causes ni-
troacetylation of 8-Oxoguanine DNA Glycosylase (Ogg1), a key enzyme
in base excision repair (BER) pathway. Nitroacetylation of Ogg1 causes
attenuation of its activity and accumulation of unrepaired 8-oxodeox-
yguanine (8-oxodG). In this condition, unrepaired SSBs can cause up-
regulation of poly(ADP-ribose) polymerase 1 (PARP1) and induction of
apoptosis [121]. Many years ago, it was suggested that modulation of
NO can reduce radiation toxicity in normal tissues [122]. It has been
confirmed that production of NO after exposure to radiation is involved
in bone marrow dysplasia and enteritis [123,124]. Inhibition of NO
generation in the bone marrow has been shown to be associated with
radioresistance of hematopoietic and marrow stromal cells [125]. Ac-
tivation of iNOS in the bone marrow stroma after exposure to radiation
B. Farhood, et al. Life Sciences 250 (2020) 117570
4
Ta
bl
e
1
Su
m
m
ar
y
re
su
lt
s
of
re
do
x
m
et
ab
ol
is
m
ta
rg
et
in
g
fo
r
m
it
ig
at
io
n
of
ra
di
at
io
n-
in
du
ce
d
no
rm
al
ti
ss
ue
in
ju
ry
.
R
ou
te
C
el
ls
/t
is
su
es
R
ad
ia
ti
on
do
se
Ta
rg
et
s
Fi
nd
in
gs
R
ef
er
en
ce
s
In
vi
tr
o
C
H
O
-K
1
3
G
y
M
it
oc
ho
nd
ri
a
In
hi
bi
ti
on
of
m
it
oc
ho
nd
ri
a
by
di
hy
dr
op
yr
id
in
es
(D
H
Ps
)
re
du
ce
s
th
e
le
ve
lo
fR
O
S
ge
ne
ra
ti
on
w
hi
ch
ca
us
e
am
el
io
ra
ti
on
of
ox
id
at
iv
e
D
N
A
da
m
ag
e.
[8
1]
M
ic
e
In
te
st
in
e
9–
10
G
y
M
it
oc
ho
nd
ri
a
JP
4-
03
9
ca
n
m
it
ig
at
e
le
th
al
eff
ec
to
fr
ad
ia
ti
on
vi
a
pr
ev
en
ti
ng
ep
it
he
lia
ln
ec
ro
si
s,
he
lp
s
re
co
ve
ry
of
st
em
ce
lls
,r
ed
uc
ti
on
of
in
fl
am
m
at
or
y
ce
lls
in
fi
lt
ra
ti
on
an
d
re
le
as
e
of
TN
F-
α.
[1
07
]
M
ic
e
Bo
ne
m
ar
ro
w
8
G
y
M
it
oc
ho
nd
ri
a
JP
4-
03
9
at
te
nu
at
es
ap
op
to
si
s
in
bo
ne
m
ar
ro
w
ce
lls
.
[1
04
]
M
ic
e
H
ea
d
an
d
ne
ck
30
G
y
M
it
oc
ho
nd
ri
a
JP
4-
03
9
ca
n
re
du
ce
se
ve
ri
ty
of
m
uc
os
it
is
.
[1
09
]
R
at
s
Lu
ng
20
G
y
M
it
oc
ho
nd
ri
a
Tr
ea
tm
en
t
w
it
h
m
et
fo
rm
in
af
te
r
ir
ra
di
at
io
n
am
el
io
ra
te
s
fi
br
os
is
.
[9
3]
M
ic
e
Bo
ne
m
ar
ro
w
7
G
y
M
it
oc
ho
nd
ri
a
M
et
fo
rm
in
ca
n
m
it
ig
at
e
ra
di
at
io
n
in
ju
ry
in
he
m
at
op
oi
et
ic
ce
lls
an
d
in
cr
ea
se
s
su
rv
iv
al
.
[9
4]
R
at
s
Lu
ng
an
d
he
ar
t
15
G
y
M
it
oc
ho
nd
ri
a
Tr
ea
tm
en
t
w
it
h
m
et
fo
rm
in
pr
e-
an
d
po
st
-i
rr
ad
ia
ti
on
re
du
ce
d
th
e
le
ve
l
of
IL
-4
,p
ne
um
on
it
is
an
d
fi
br
os
is
.
[9
0,
89
]
M
ic
e
K
id
ne
y
8
G
y
m
TO
R
R
ap
am
yc
in
ad
m
in
is
tr
at
io
n
af
te
r
w
ho
le
-b
od
y
ir
ra
di
at
io
n
ca
n
in
du
ce
re
po
pu
la
ti
on
of
re
na
l
st
em
ce
lls
,t
hu
s
am
el
io
ra
te
s
ne
ph
ro
to
xi
ci
ty
.
[4
3]
M
ic
e
Pa
ro
ti
d
gl
an
ds
5
G
y
m
TO
R
In
hi
bi
ti
on
of
m
TO
R
by
ra
pa
lo
gu
e
(C
C
I-
77
9)
ca
n
au
gm
en
t
th
e
nu
m
be
r
of
ce
lls
in
pa
ro
ti
d
gl
an
ds
,w
hi
le
no
hy
pe
rp
la
si
a
w
as
ob
se
rv
ed
fo
r
m
an
di
bu
la
r
gl
an
ds
.
[4
5]
M
ic
e
Lu
ng
5
×
6
G
y
m
TO
R
Tr
ea
tm
en
t
w
it
h
ra
pa
m
yc
in
st
ar
ti
ng
2
da
ys
be
fo
re
ir
ra
di
at
io
n
fo
r
16
w
ee
ks
le
d
to
re
du
ct
io
n
of
se
ne
sc
en
ce
an
d
pu
lm
on
ar
y
fi
br
os
is
.
R
ap
am
yc
in
al
so
ca
us
ed
re
du
ct
io
n
of
m
ac
ro
ph
ag
e
in
fi
lt
ra
ti
on
in
to
th
e
lu
ng
.
[4
9]
M
ic
e
To
ng
ue
5
×
6
G
y
m
TO
R
R
ap
am
yc
in
in
du
ce
d
th
e
ac
ti
va
ti
on
of
M
nS
O
D
,
w
hi
ch
pr
ev
en
te
d
se
ne
sc
en
ce
in
st
em
ce
lls
as
w
el
l
as
m
uc
os
it
is
.
[4
6]
In
vi
tr
o
M
ur
in
e
m
ic
ro
gl
ia
ce
lls
10
G
y
PP
A
R
б
R
ed
uc
ti
on
in
th
e
le
ve
l
of
in
fl
am
m
at
or
y
m
ed
ia
to
rs
an
d
cy
to
ki
ne
s,
an
d
al
so
re
du
ce
d
ox
id
at
iv
e
st
re
ss
ob
se
rv
ed
fo
llo
w
in
g
ac
ti
va
ti
on
of
PP
A
R
б.
[5
7]
In
vi
tr
o
M
ur
in
e
m
ic
ro
gl
ia
ce
lls
2–
10
G
y
PP
A
R
α
A
ct
iv
at
io
n
of
PP
A
R
α
ca
us
ed
a
re
du
ct
io
n
in
in
fl
am
m
at
or
y
m
ar
ke
rs
in
cl
ud
in
g
N
F-
κB
an
d
A
P-
1.
[5
8]
M
ic
e
Br
ai
n
10
G
y
PP
A
R
α
A
ct
iv
at
io
n
of
PP
A
R
α
us
in
g
fe
no
fi
br
at
e
co
ul
d
pr
es
er
ve
th
e
hi
pp
oc
am
pu
s
af
te
r
w
ho
le
-b
ra
in
ir
ra
di
at
io
n.
[5
9 ]
M
ic
e
K
id
ne
y
10
G
y
PP
A
R
α
K
no
ck
ou
t
of
PP
A
R
α
in
cr
ea
se
d
th
e
ex
pr
es
si
on
of
N
F-
κB
;h
ow
ev
er
,i
t
pr
ot
ec
te
d
ki
dn
ey
ce
lls
vi
a
in
hi
bi
ti
on
of
ap
op
to
si
s.
[5
4]
M
ic
e
In
te
st
in
e
12
G
y
PP
A
R
γ
A
ct
iv
at
io
n
of
PP
A
R
γ
ca
n
re
du
ce
ra
di
at
io
n
to
xi
ci
ty
in
th
e
in
te
st
in
e
vi
a
su
pp
re
ss
io
n
of
ap
op
to
si
s
an
d
in
fl
am
m
at
io
n.
[6
0]
M
ic
e
Lu
ng
19
G
y
PP
A
R
γ
R
os
ig
lit
az
on
e
as
an
ag
on
is
t
of
PP
A
R
γ
at
te
nu
at
ed
pn
eu
m
on
it
is
an
d
fi
br
os
is
fo
llo
w
in
g
do
w
nr
eg
ul
at
io
n
of
N
F-
κB
an
d
TG
F-
β.
[6
1]
M
ic
e
H
ea
d
an
d
ne
ck
16
.5
G
y
PP
A
R
γ
Su
pp
re
ss
io
n
of
N
F-
κB
an
d
TG
F-
β
fo
llo
w
in
g
PP
A
R
γ
ac
ti
va
ti
on
sh
ow
ed
am
el
io
ra
ti
on
of
m
uc
os
it
is
.
[6
2]
In
vi
tr
o
H
um
an
pu
lm
on
ar
y
ar
te
ry
en
do
th
el
ia
l
ce
lls
(H
PA
EC
s)
5
G
y
N
O
X
1
N
O
X
1
po
te
nt
ia
te
s
pu
lm
on
ar
y
fi
br
os
is
.
[6
3]
In
vi
tr
o
sa
liv
ar
y
gl
an
d
ac
in
ar
ce
lls
(N
S-
SV
-A
C
)
10
G
y
N
O
X
1
Su
pe
ro
xi
de
pr
od
uc
ti
on
by
N
O
X
1
m
ed
ia
te
s
ap
op
to
si
s
in
ir
ra
di
at
ed
ce
lls
.
[6
4]
In
vi
tr
o
H
um
an
fi
br
ob
la
st
s
2–
10
G
y
N
O
X
4&
5
In
ac
ti
va
ti
on
of
N
O
X
4
an
d
N
O
X
5
ca
n
re
du
ce
ox
id
at
iv
e
st
re
ss
an
d
D
N
A
in
ju
ry
af
te
r
ex
po
su
re
to
ra
di
at
io
n.
[6
5]
R
at
s
Lu
ng
2
G
y
N
O
X
2&
4
Lo
ca
liz
ed
pe
lv
is
ir
ra
di
at
io
n
le
d
to
up
re
gu
la
ti
on
of
N
O
X
2
an
d
N
O
X
4.
A
dm
in
is
tr
at
io
n
of
m
el
at
on
in
co
ul
d
at
te
nu
at
e
th
e
up
re
gu
la
ti
on
of
th
es
e
ge
ne
s.
[1
38
]
B. Farhood, et al. Life Sciences 250 (2020) 117570
5
can cause damage to transplanted hematopoietic or stem cells [123].
Infiltration of macrophages after exposure to ionizing radiation can be a
sign of NO production. Pneumonitis after lung exposure to radiation is a
known consequence of infiltration of inflammatory cells. Production of
NO by macrophages has a role in the progression of pneumonitis. In-
hibition of iNOS by N(G)-nitro-L-arginine methyl ester (L-NAME) in a
rat model showed remarkable reduction in inflammation and fibrosis
[126]. In contrast to these results, some evidences have shown that
disruption of NO generation and overproduction of ROS by NADPH
oxidase are responsible for vascular injuries after exposure to ionizing
radiation [127]. Anti-inflammatory and antioxidant agents which
neutralize both ROS and NO could be appropriate for mitigating ra-
diation injury via boosting DNA repair and overcoming oxidative stress.
NO has a dual effect on cancer and may cause both cell death and
angiogenesis [128]. Although selective targeting of NO may not be
applicable for radiotherapy, NO scavengers are promising for mitiga-
tion of radiation toxicity [111,129].
9. Epigenetic regulators of redox reactions
It has been confirmed that some epigenetic modulators such as
microRNAs are able to change redox state through regulation of anti-
oxidant or pro-oxidant agents [130] (Table 1). MiR-21 is one of the
most common players in the epigenetic modulation of oxidative stress
following exposure to ionizing radiation. It has been shown that miR-21
is triggered by TGF-β [131,132]. On the other hand, miR-21 causes
suppression of SOD2, leading to overcoming superoxide generation on
the antioxidant defense of cells [133,134]. MiR-22 can also increase
ROS derived mitochondria, thus induces apoptosis [135]. Recently, it
has been shown that this pathway plays a role in apoptosis of bone
marrow stem cells [136]. Its inhibition and that of some other
microRNAs such as miR-214 that are involved in oxidative injury, have
been shown to ameliorate radiation toxicity in irradiated cells [137]
(Fig. 2).
10. Conclusion
As explained in this review, cell metabolism is an important target
for mitigation of radiation injury. The most part of cell metabolism for
mitigation of radiation injury is related to abnormal increased genera-
tion of free radicals including both ROS and NO. Mitochondria are the
major source of free radicals for a wide range of cells. Targeting mi-
tochondrial ROS by mitochondrial ROS scavengers and SOD mimicking
antioxidants confirms its pivotal role in radiation toxicity. NADPH
oxidase enzymes are involved in radiation-induced injury in some or-
gans such as bone marrow, intestine and lung. These enzymes can be
activated by both immune and non-immune cells. COX-2 and iNOS are
regulated mainly by inflammatory cells and have a role in inflammatory
reactions and fibrosis in some organs like lung, neurovascular and
gastrointestinal system. Treatments with antioxidants and anti-in-
flammatory agents have been shown to mitigate radiation toxicity via
neutralization of free radicals and attenuation of these enzymes.
Moreover, some other mechanisms including mTOR and PPARs which
are activated by ionizing radiation mediate cell death mainly through
senescence. This is very important for late effects of ionizing radiation
such as fibrosis.
Funding
This study received no funding.
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